Agrylin anagrelide inhibitor of cyclic AMP phosphodiesterase regulatory update

Europe granted Orphan Drug

Read the full 44 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE